Randomized placebo controlled trials of n-acetyl cysteine as adjunct therapy for schizophrenia and bipolar disorder
Contribuinte(s) |
[Unknown] |
---|---|
Data(s) |
01/01/2009
|
Resumo |
Glutathione is the principal antioxidant of the brain. There is evidence of oxidative stress, lowered brain glutathione and genetic linkage involve glutathione metabolic genes in schizophrenia and bipolar disorder. N-acetyl cysteine (NAC) is a safe, orally bioavailable, precursor of glutathione. NAC has been shown to reverse animal models of oxidative stress, and raises brain glutathione levels.<br /> |
Identificador | |
Idioma(s) |
eng |
Publicador |
World Federation of Societies of Biological Psychiatry |
Relação |
http://dro.deakin.edu.au/eserv/DU:30035451/dean-randomizedplacebo-2009.pdf |
Direitos |
2009, World Federation of Societies of Biological Psychiatry |
Tipo |
Conference Paper |